Effects of transcranial magnetic stimulation combined with extracorporeal shockwave therapy for poststroke spasticity: study protocol for a randomised controlled trial

Introduction Spasticity is a common complication of stroke, which is related to poor motor recovery and limitations in the performance of activities. Both transcranial magnetic stimulation (TMS) and extracorporeal shockwave therapy (ESWT) are effective treatment methods for poststroke spasticity (PS...

Full description

Saved in:
Bibliographic Details
Main Authors: Man Yang, Lu Liu, Peng-Yu Wang, Yang Zhu, Ling-Yi Liao, Qiu-Yi Peng, Yong Tao, Jin-Jing Liu, Xiang-Qin Fang, Shi-Hao Gao, Chang-Yue Gao
Format: Article
Language:English
Published: BMJ Publishing Group 2025-01-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/1/e086300.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841560560816095232
author Man Yang
Lu Liu
Peng-Yu Wang
Yang Zhu
Ling-Yi Liao
Qiu-Yi Peng
Yong Tao
Jin-Jing Liu
Xiang-Qin Fang
Shi-Hao Gao
Chang-Yue Gao
author_facet Man Yang
Lu Liu
Peng-Yu Wang
Yang Zhu
Ling-Yi Liao
Qiu-Yi Peng
Yong Tao
Jin-Jing Liu
Xiang-Qin Fang
Shi-Hao Gao
Chang-Yue Gao
author_sort Man Yang
collection DOAJ
description Introduction Spasticity is a common complication of stroke, which is related to poor motor recovery and limitations in the performance of activities. Both transcranial magnetic stimulation (TMS) and extracorporeal shockwave therapy (ESWT) are effective treatment methods for poststroke spasticity (PSS). However, there is no existing study exploring the safety and effectiveness of TMS combined with ESWT for PSS.Methods and analysis This study will be a prospective, single-centre, randomised, factorial, controlled clinical trial. In this trial, 136 patients with PSS will be randomly divided into 4 groups: experimental group 1 (TMS), experimental group 2 (ESWT), experimental group 3 (ESWT+TMS) and control group, 34 patients in each group; all patients received routine rehabilitation. Outcome measures will be assessed by 4 time points: baseline (T0), 2 weeks after initiation of treatment (T1), 4 weeks after initiation of treatment (T2) and follow-up (4 weeks after the end of treatment, T3). The primary outcome is the modified Ashworth scale at T2. The secondary outcomes include the modified Tardieu scale for the degree of spasticity, the Fugl-Meyer assessment scale and range of motion (ROM) for motor function, the stroke-specific quality of life scale (SS-QOL) and modified Barthel index for activities of life, cortical excitability measured by TMS–surface electromyography (EMG), cerebral cortex oxygen concentrations measured by functional near-infrared spectroscopy (fNIRS) and Hmax/Mmax ratio measured by EMG.Ethics and dissemination This study protocol was approved by the Ethics Committee of the Army Medical Center of PLA (Approval No. 2024-04) on 24 January 2024. The study will be disseminated through peer-reviewed publications and conference presentations.Trial registration number This study was registered in the Chinese Clinical Trial Registry (https://www.chictr.org.cn/; unique identifier: ChiCTR2400080862; data: 9 February 2024; study protocol V. 2.0).
format Article
id doaj-art-712604023e8b4efb80205b3091f2e1e9
institution Kabale University
issn 2044-6055
language English
publishDate 2025-01-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-712604023e8b4efb80205b3091f2e1e92025-01-04T02:30:09ZengBMJ Publishing GroupBMJ Open2044-60552025-01-0115110.1136/bmjopen-2024-086300Effects of transcranial magnetic stimulation combined with extracorporeal shockwave therapy for poststroke spasticity: study protocol for a randomised controlled trialMan Yang0Lu Liu1Peng-Yu Wang2Yang Zhu3Ling-Yi Liao4Qiu-Yi Peng5Yong Tao6Jin-Jing Liu7Xiang-Qin Fang8Shi-Hao Gao9Chang-Yue Gao101 Department of Rehabilitation, Daping Hospital, Army Medical University, Chongqing, China1 Department of Rehabilitation, Daping Hospital, Army Medical University, Chongqing, China2 Department of Health Statistics, College of Preventive Medicine, Army Medical University, Chongqing, China1 Department of Rehabilitation, Daping Hospital, Army Medical University, Chongqing, China1 Department of Rehabilitation, Daping Hospital, Army Medical University, Chongqing, China1 Department of Rehabilitation, Daping Hospital, Army Medical University, Chongqing, China1 Department of Rehabilitation, Daping Hospital, Army Medical University, Chongqing, China1 Department of Rehabilitation, Daping Hospital, Army Medical University, Chongqing, China1 Department of Rehabilitation, Daping Hospital, Army Medical University, Chongqing, China1 Department of Rehabilitation, Daping Hospital, Army Medical University, Chongqing, China1 Department of Rehabilitation, Daping Hospital, Army Medical University, Chongqing, ChinaIntroduction Spasticity is a common complication of stroke, which is related to poor motor recovery and limitations in the performance of activities. Both transcranial magnetic stimulation (TMS) and extracorporeal shockwave therapy (ESWT) are effective treatment methods for poststroke spasticity (PSS). However, there is no existing study exploring the safety and effectiveness of TMS combined with ESWT for PSS.Methods and analysis This study will be a prospective, single-centre, randomised, factorial, controlled clinical trial. In this trial, 136 patients with PSS will be randomly divided into 4 groups: experimental group 1 (TMS), experimental group 2 (ESWT), experimental group 3 (ESWT+TMS) and control group, 34 patients in each group; all patients received routine rehabilitation. Outcome measures will be assessed by 4 time points: baseline (T0), 2 weeks after initiation of treatment (T1), 4 weeks after initiation of treatment (T2) and follow-up (4 weeks after the end of treatment, T3). The primary outcome is the modified Ashworth scale at T2. The secondary outcomes include the modified Tardieu scale for the degree of spasticity, the Fugl-Meyer assessment scale and range of motion (ROM) for motor function, the stroke-specific quality of life scale (SS-QOL) and modified Barthel index for activities of life, cortical excitability measured by TMS–surface electromyography (EMG), cerebral cortex oxygen concentrations measured by functional near-infrared spectroscopy (fNIRS) and Hmax/Mmax ratio measured by EMG.Ethics and dissemination This study protocol was approved by the Ethics Committee of the Army Medical Center of PLA (Approval No. 2024-04) on 24 January 2024. The study will be disseminated through peer-reviewed publications and conference presentations.Trial registration number This study was registered in the Chinese Clinical Trial Registry (https://www.chictr.org.cn/; unique identifier: ChiCTR2400080862; data: 9 February 2024; study protocol V. 2.0).https://bmjopen.bmj.com/content/15/1/e086300.full
spellingShingle Man Yang
Lu Liu
Peng-Yu Wang
Yang Zhu
Ling-Yi Liao
Qiu-Yi Peng
Yong Tao
Jin-Jing Liu
Xiang-Qin Fang
Shi-Hao Gao
Chang-Yue Gao
Effects of transcranial magnetic stimulation combined with extracorporeal shockwave therapy for poststroke spasticity: study protocol for a randomised controlled trial
BMJ Open
title Effects of transcranial magnetic stimulation combined with extracorporeal shockwave therapy for poststroke spasticity: study protocol for a randomised controlled trial
title_full Effects of transcranial magnetic stimulation combined with extracorporeal shockwave therapy for poststroke spasticity: study protocol for a randomised controlled trial
title_fullStr Effects of transcranial magnetic stimulation combined with extracorporeal shockwave therapy for poststroke spasticity: study protocol for a randomised controlled trial
title_full_unstemmed Effects of transcranial magnetic stimulation combined with extracorporeal shockwave therapy for poststroke spasticity: study protocol for a randomised controlled trial
title_short Effects of transcranial magnetic stimulation combined with extracorporeal shockwave therapy for poststroke spasticity: study protocol for a randomised controlled trial
title_sort effects of transcranial magnetic stimulation combined with extracorporeal shockwave therapy for poststroke spasticity study protocol for a randomised controlled trial
url https://bmjopen.bmj.com/content/15/1/e086300.full
work_keys_str_mv AT manyang effectsoftranscranialmagneticstimulationcombinedwithextracorporealshockwavetherapyforpoststrokespasticitystudyprotocolforarandomisedcontrolledtrial
AT luliu effectsoftranscranialmagneticstimulationcombinedwithextracorporealshockwavetherapyforpoststrokespasticitystudyprotocolforarandomisedcontrolledtrial
AT pengyuwang effectsoftranscranialmagneticstimulationcombinedwithextracorporealshockwavetherapyforpoststrokespasticitystudyprotocolforarandomisedcontrolledtrial
AT yangzhu effectsoftranscranialmagneticstimulationcombinedwithextracorporealshockwavetherapyforpoststrokespasticitystudyprotocolforarandomisedcontrolledtrial
AT lingyiliao effectsoftranscranialmagneticstimulationcombinedwithextracorporealshockwavetherapyforpoststrokespasticitystudyprotocolforarandomisedcontrolledtrial
AT qiuyipeng effectsoftranscranialmagneticstimulationcombinedwithextracorporealshockwavetherapyforpoststrokespasticitystudyprotocolforarandomisedcontrolledtrial
AT yongtao effectsoftranscranialmagneticstimulationcombinedwithextracorporealshockwavetherapyforpoststrokespasticitystudyprotocolforarandomisedcontrolledtrial
AT jinjingliu effectsoftranscranialmagneticstimulationcombinedwithextracorporealshockwavetherapyforpoststrokespasticitystudyprotocolforarandomisedcontrolledtrial
AT xiangqinfang effectsoftranscranialmagneticstimulationcombinedwithextracorporealshockwavetherapyforpoststrokespasticitystudyprotocolforarandomisedcontrolledtrial
AT shihaogao effectsoftranscranialmagneticstimulationcombinedwithextracorporealshockwavetherapyforpoststrokespasticitystudyprotocolforarandomisedcontrolledtrial
AT changyuegao effectsoftranscranialmagneticstimulationcombinedwithextracorporealshockwavetherapyforpoststrokespasticitystudyprotocolforarandomisedcontrolledtrial